MedTrace Logo

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

NCT02392078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1153

Last updated 2025-04-24

Study results available
· View outcomes & findings →

Summary

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 3,000 patients and up to 50 sites.

Conditions

Interventions

DEVICE

NeuroBlate System

Sponsors & Collaborators

  • Monteris Medical

    lead INDUSTRY

Principal Investigators

  • Eric Leuthardt, MD · Washington University School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02392078 on ClinicalTrials.gov